RxDoctor Payments Data

Jenney Garrett

Nurse Practitioner · Conway, ARNPI 1336808674

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.0% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Amgen at 28.4% of the total. Among nurse practitioner clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,594in general payments, 2019–2025

Across 231 payments — averaging $24.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Novartis$433
  • Bayer$427
  • AstraZeneca$420
  • Ardelyx, Inc.$359
  • Travere Therapeutics, Inc.$335
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$5,31695%
  • Education$2785%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,594 in reported general payments places this provider in the 90th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
XphozahTenapanor Hcl12$103,662
RenvelaSevelamer Carbonate22$42,564
Sevelamer Carbonate122$32,064
AuryxiaFerric Citrate12$22,091
LinzessLinaclotide13$6,916
ClinolipidFat Emulsion/Olive/Soy/Phospho16$4,320
Midodrine Hcl19$3,214
Calcium Acetate44$2,502
Nifedipine ErNifedipine54$1,148
Rosuvastatin Calcium14$1,060
Lidocaine-PrilocaineLidocaine/Prilocaine59$1,039
Hydralazine Hcl49$514
Pantoprazole Sodium28$507
Ondansetron Hcl16$476
Potassium Chloride28$417

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Akebia Therapeutics IncAuryxia$19$22,09112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 697 nurse practitioner providers in Arkansas.

Other nurse practitioner in Conway

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →